These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35695006)

  • 1. Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Stenosis: A Multicenter Randomized Phase II Trial.
    Uphaus T; Richards T; Weimar C; Neugebauer H; Poli S; Weissenborn K; Imray C; Michalski D; Rashid H; Loftus I; Rummey C; Ritter M; Hauser TK; Münch G; Gröschel K; Poppert H
    Stroke; 2022 Sep; 53(9):2718-2729. PubMed ID: 35695006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease: The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial.
    Mayer K; Hein-Rothweiler R; Schüpke S; Janisch M; Bernlochner I; Ndrepepa G; Sibbing D; Gori T; Borst O; Holdenrieder S; Kupka D; Petzold T; Bradaric C; Okrojek R; Leistner DM; Trippel TD; Münzel T; Landmesser U; Pieske B; Zeiher AM; Gawaz MP; Hapfelmeier A; Laugwitz KL; Schunkert H; Kastrati A; Massberg S
    JAMA Cardiol; 2021 Jul; 6(7):753-761. PubMed ID: 33787834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revacept, an Inhibitor of Platelet Adhesion in Symptomatic Carotid Artery Stenosis: Design and Rationale of a Randomized Phase II Clinical Trial.
    Gröschel K; Uphaus T; Loftus I; Poppert H; Diener HC; Zobel J; Münch G
    TH Open; 2020 Oct; 4(4):e393-e399. PubMed ID: 33274312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revacept, a Novel Inhibitor of Platelet Adhesion, in Patients Undergoing Elective PCI-Design and Rationale of the Randomized ISAR-PLASTER Trial.
    Schüpke S; Hein-Rothweiler R; Mayer K; Janisch M; Sibbing D; Ndrepepa G; Hilz R; Laugwitz KL; Bernlochner I; Gschwendtner S; Kupka D; Gori T; Zeiher AM; Schunkert H; Massberg S; Kastrati A;
    Thromb Haemost; 2019 Sep; 119(9):1539-1545. PubMed ID: 31226721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GPVI-Fc fusion protein Revacept improves cerebral infarct volume and functional outcome in stroke.
    Goebel S; Li Z; Vogelmann J; Holthoff HP; Degen H; Hermann DM; Gawaz M; Ungerer M; Münch G
    PLoS One; 2013; 8(7):e66960. PubMed ID: 23935828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial.
    Yaghi S; de Havenon A; Rostanski S; Kvernland A; Mac Grory B; Furie KL; Kim AS; Easton JD; Johnston SC; Henninger N
    Stroke; 2021 Jul; 52(7):2414-2417. PubMed ID: 33940954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.
    Markus HS; Droste DW; Kaps M; Larrue V; Lees KR; Siebler M; Ringelstein EB
    Circulation; 2005 May; 111(17):2233-40. PubMed ID: 15851601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.
    Jing J; Meng X; Zhao X; Liu L; Wang A; Pan Y; Li H; Wang D; Johnston SC; Wang Y; Wang Y
    JAMA Neurol; 2018 Jun; 75(6):711-719. PubMed ID: 29582084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative antithrombotic treatment in acutely symptomatic carotid artery stenosis.
    Martinez-Gutierrez JC; Roy AT; D'Amato S; Berkman JM; Montes D; Kimball CA; Rordorf GA; Chibnik LB; Romero JM; Silverman SB
    J Stroke Cerebrovasc Dis; 2022 May; 31(5):106396. PubMed ID: 35219972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in Patients With Significant Carotid Artery Disease.
    Kashyap VS; Schneider PA; Foteh M; Motaganahalli R; Shah R; Eckstein HH; Henao S; LaMuraglia G; Stoner MC; Melton J; Massop D; Hanover T; Titus J; Moore WS; Rodríguez-Carvajal R; Malas MB; Arko FR; Pierce D; Anain P; Oskin T;
    Stroke; 2020 Sep; 51(9):2620-2629. PubMed ID: 32811386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel antiplatelet drug revacept (Dimeric Glycoprotein VI-Fc) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans.
    Ungerer M; Rosport K; Bültmann A; Piechatzek R; Uhland K; Schlieper P; Gawaz M; Münch G
    Circulation; 2011 May; 123(17):1891-9. PubMed ID: 21502572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes and strategy of tailored antiplatelet therapy with ticagrelor in patients undergoing transcarotid artery revascularization.
    Ghamraoui AK; Ricotta JJ
    J Vasc Surg; 2021 Jan; 73(1):132-141. PubMed ID: 32445834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
    Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM
    Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.
    Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC
    JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis.
    Kwon SU; Hong KS; Kang DW; Park JM; Lee JH; Cho YJ; Yu KH; Koo JS; Wong KS; Lee SH; Lee KB; Kim DE; Jeong SW; Bae HJ; Lee BC; Han MK; Rha JH; Kim HY; Mok VC; Lee YS; Kim GM; Suwanwela NC; Yun SC; Nah HW; Kim JS
    Stroke; 2011 Oct; 42(10):2883-90. PubMed ID: 21799173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis.
    Ntaios G; Swaminathan B; Berkowitz SD; Gagliardi RJ; Lang W; Siegler JE; Lavados P; Mundl H; Bornstein N; Meseguer E; Amarenco P; Cucchiara B; Camps-Renom P; Makaritsis K; Korompoki E; Papavasileiou V; Marti-Fabregas J; Milionis H; Vemmos K; Connolly SJ; Hart RG;
    Stroke; 2019 Sep; 50(9):2477-2485. PubMed ID: 31401971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Carotid Endarterectomy for Symptomatic Stenosis of Internal Carotid Artery in Patients Affected by Transient Ischemic Attack or Minor-to-Moderate Ischemic Acute Stroke: A Single-Center Experience.
    Borghese O; Pisani A; Lapergue B; Di Centa I
    Ann Vasc Surg; 2020 May; 65():232-239. PubMed ID: 31705984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
    Wong KS; Chen C; Fu J; Chang HM; Suwanwela NC; Huang YN; Han Z; Tan KS; Ratanakorn D; Chollate P; Zhao Y; Koh A; Hao Q; Markus HS;
    Lancet Neurol; 2010 May; 9(5):489-97. PubMed ID: 20335070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet inhibition by adjunctive cilostazol suppresses the frequency of cerebral ischemic lesions after carotid artery stenting in patients with carotid artery stenosis.
    Nakagawa I; Wada T; Park HS; Nishimura F; Yamada S; Nakagawa H; Kichikawa K; Nakase H
    J Vasc Surg; 2014 Mar; 59(3):761-7. PubMed ID: 24239116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low risk of ischemic stroke in patients with reduced internal carotid artery lumen diameter distal to severe symptomatic carotid stenosis: cerebral protection due to low poststenotic flow? On behalf of the European Carotid Surgery Trialists' Collaborative Group.
    Rothwell PM; Warlow CP
    Stroke; 2000 Mar; 31(3):622-30. PubMed ID: 10700495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.